Thursday, April 15, 2021
Home Life Style Health & Fitness Anti-Viral Drug Remdesivir Does Not Effect Hospitalized COVID Patients: WHO

Anti-Viral Drug Remdesivir Does Not Effect Hospitalized COVID Patients: WHO

Remdesivir Drug is Not Helpful in Recovery of COVID Patients

Anti-viral drug Remdesivir has little or no effect in the recovery and mortality of hospitalized COVID-19 patients, said a World Health Organisation (WHO) study, giving a big blow to the hope that the drug from US-based Gilead Sciences raised in combating the pandemic.

The WHO said that the Solidarity Therapeutics Trial produced “conclusive evidence” on the effectiveness of repurposed drugs for COVID-19 in record time — just six months.

Interim results from the world’s largest randomized control trial on COVID-19 therapeutics have been uploaded as a preprint at medRxiv, the WHO said, adding that the results are under review for publication in a medical journal.

Follow NewsGram on Instagram to keep yourself updated.

The study, which spans more than 30 countries, looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalized patients.

Remdesivir
Anti-viral drug Remdesivir has little or no effect in the recovery and mortality of hospitalized Covid-19 patients, said a World Health Organisation. Unsplash

The results from the study indicate that Remdesivir, hydroxychloroquine, lopinavir/ritonavir, and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.

“These Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens appeared to have little or no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation and duration of hospital stay,” said the study.

Also Read: Antibodies of Patients With Severe Covid-19 Affect Immune System: Study

The study conducted in 405 hospitals across 30 countries involved 11,266 adults.

Remdesivir was the only drug that received Emergency Use Authorisation for Covid-19 from the US Food and Drug Administration. (IANS)

STAY CONNECTED

19,517FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

Know About The Term ‘Gaslighting’ Growing In Popularity

Gaslighting. A term used so frequently by millennials and a concept that has been growing in popularity. So, what is 'gaslighting' you ask? It...

A Few Tips To Keep Yourself Anxiety-Free During The Pandemic Scare

Anxiety is our body's natural response to stress. It's a feeling of fear or apprehension about what's to come. On the first day of...

Pandemic Made Us Realize The Importance Of Going Digital

For 28-year-old Pratyush Ranjan, the Covid-hit 2020 taught him hard lessons in embracing a digital life, not only for shopping clothes or shoes but...

Study: Obese Or Overweight Patients At Higher Risk Of Severe COVID

Patients who are overweight or obese are likely to have more severe Covid-19 and are highly likely to require invasive respiratory support, a new...

Explore The Range Of Dates For The Holy Month

Muslims across the world break their Ramadan fast with a date as it was guided by the Prophet. Although dates are loaded with a...

Second COVID Wave Super Dangerous For Kids: Health Experts

In what should worry Indian parents the most, an increasing number of children are now being infected with Covid-19 along with serious symptoms in...

Facebook: India Ranked 49th In World Internet Inclusion

Despite the cheapest data plans and nearly 700 million internet users, India is at a dismal 49th spot globally when it comes to internet...

Hindko: ‘The Language Of Hind’

By- Khushi Bisht "Hindko" is a Pashto (an eastern Iranian language) word that was originally translated as the 'language of Hind.' Hindko, which many people...

Recent Comments